Abstract
We report a case of acute myeloid leukemia (AML), M2 subtype according to the French-American-British (FAB) classification, with extramedullary myeloblastoma of the uterus and a masked type of variant translocation of t(8;21)(q22;q22). A 45-year-old Japanese woman presented with metrorrhagia, and AML (M2) with uterine invasion was diagnosed. The patient received an allogeneic peripheral blood stem cell transplantation after remission, and her pelvis was irradiated locally. Cytogenetic study at first showed t(8;17)(q22;p13) by G-banding. Spectral karyotyping (SKY) analysis modified this interpretation to a 3-way translocation involving chromosomes 8, 17, and 21 and identified a masked type of variant t(8;21)(q22;q22) translocation. Results of fluorescence in situ hybridization using theAML1/ETO probe, and of detection of theAML1/ETO fusion transcript by reverse transcriptase—polymerase chain reaction were consistent with the karyotyping result. SKY analysis is useful to compensate for the limitations of cytogenetic studies.Int J Hematol. 2002;76:338-343.
Similar content being viewed by others
References
Rowley JD. Recurring chromosome abnormalities in leukemia and lymphoma.Semin Hematol. 1990;27:122–136.
Mitelman F, Heim S. Quantitative acute leukemia cytogenetics.Genes Chromosomes Cancer. 1992;5:57–66.
Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group.Ann Intern Med. 1985;103:620–625.
Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.Blood. 1996;88: 1813–1823.
Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.EMBO J. 1993;12:2715–2721.
Kurokawa M, Tanaka T, Tanaka K, et al. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts.J Biol Chem. 1996;271:16870–16876.
Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie house, Virginia, November 1997.Mod Pathol. 2000;13:193–207.
Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ. 8:21 translocation in acute granulocytic leukemia: cytological, cytochemical and clinical features.Br J Haematol. 1984;56:119–213.
Veldman T,Vignon C, SchrÖck E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.Nat Genet. 1997;15:406–410.
Kakazu N, Taniwaki M, Horiike S, et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.Genes Chromosomes Cancer. 1999; 26:336–345.
Kakazu N, Kito K, Hitomi T, et al. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomere probe.Am J Hematol. 2000;65:291–297.
Hirai K, Torimoto Y, Moriichi K, et al. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.Int J Hematol. 1999;70:30–35.
Hoshida Y, Hongyo T, Nakatsuka S, et al. Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes develop- ing in renal transplant patients.Lab Invest. 2002;82:257–264.
Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.J Clin Oncol. 1995;13:1800–1816.
Iizuka Y, Aiso M, Oshimi K, et al. Myeloblastoma formation in acute myeloid leukemia.Leuk Res. 1992;16:665–671.
Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21) (q22;q22).Blood. 1997;90:1643–1648.
Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.J Clin Oncol. 1997;15:466–475.
Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ, Variakojis D. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.J Clin Oncol. 1993;11:690–697.
Kyo T. Characteristic clinical features and treatment of acute myelocytic leukemia with 8;21 translocation [in Japanese].Jpn J Clin Hematol. 1994;35:245–249.
Yamada K, Furusawa S. Preferential involvement of chromosomes no. 8 and no. 21 in acute leukemia and preleukemia.Blood. 1976; 47:679–686.
Jonveaux P, Fenaux P, Quiquandon I, et al. Mutations in the p53 gene in myelodysplastic syndromes.Oncogene. 1991;6:2243–2247.
Lai JL, Preudhomme C, Zandecki M, et al. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.Leukemia. 1995;9:370–381.
Soenen V, Preudhomme C, Roumier C, Daudignon A, Laü JL, Fenaux P. 17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.Blood. 1998;91:1008–1015.
Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types.Nature. 1989;342:705–708.
Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers.Science. 1991;253:49–53.
Saitoh K, Miura I, Ohshima A, et al. Translocation (8;12;21) (q22.1;q24.1;q22.1): a new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia.Cancer Genet Cytogenet. 1997;96:111–114.
Harrison CJ, Radford-Weiss I, Ross F, et al. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations.Cancer Genet Cytogenet. 1999;112:15–20.
Mohr B, Bornhäuser M, Thiede C, et al. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome.Leukemia. 2000;14:1031–1038.
Hilgenfeld E, Padilla-Nash H, McNeil N, et al. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.Br J Haematol. 2001;113:305–317.
Kerndrup GB, Kjeldsen E. Acute leukemia cytogenetics: an evaluation of combining G-band karyotyping with multi-color spectral karyotyping.Cancer Genet Cytogenet. 2001;124:7–11.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Miyagi, Ji., Kakazu, N., Masuda, M. et al. Acute Myeloid Leukemia (FAB-M2) with a Masked Type of t(8;21) Translocation Revealed by Spectral Karyotyping. Int J Hematol 76, 338–343 (2002). https://doi.org/10.1007/BF02982693
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982693